-
Novel Blood Test Could Help Diagnose, Track Alzheimer’s
09 Apr 2025 10:26 GMT
… include AbbVie, ADDF, ALZpath, Asteroid, Avid Radiopharmaceuticals, BioArctic, Biogen, Bristol Myers Squibb …
-
Breakthrough Drug Cuts Alzheimer’s Risk by 50% in High-Risk Patients
26 Mar 2025 17:22 GMT
… Company; F. Hoffman-LaRoche Ltd.; Avid Radiopharmaceuticals (a wholly owned subsidiary of …
-
Anti-Amyloid Drug Shows Promise in Preventing Alzheimer’s
20 Mar 2025 11:17 GMT
… Company; F. Hoffman-LaRoche Ltd.; Avid Radiopharmaceuticals (a wholly owned subsidiary of … Company; F. Hoffman-LaRoche Ltd.; Avid Radiopharmaceuticals (a wholly owned subsidiary of …
-
Experimental drug shows promise in reducing risk of Alzheimer's-related dementia
20 Mar 2025 01:43 GMT
… Company; F. Hoffman-LaRoche Ltd.; Avid Radiopharmaceuticals (a wholly owned subsidiary of …
-
Global Alzheimer’s Platform Foundation Announces Strategic Collaboration with Eli Lilly and Company for the Transformative Bio-Hermes-002 Study
09 Dec 2024 15:00 GMT
… and Company and president of Avid Radiopharmaceuticals. “The Bio-Hermes-002 study …
-
Certain kinds of dementia could affect empathy
03 Dec 2024 16:53 GMT
… reported receiving grants from ADx, AVID Radiopharmaceuticals,
Biogen, Eli Lilly, Eisai, Fujirebio …
-
MHRA approves Eli Lilly’s Alzheimer’s diagnostic imaging agent Tauvid
28 Nov 2024 13:41 GMT
… developed by Eli Lilly subsidiary Avid Radiopharmaceuticals, to identify whether patients with …
-
Men at high risk of cardiovascular disease face brain health decline 10 years earlier than women
27 Nov 2024 01:21 GMT
… Science/Life Molecular Imaging, Avid Radiopharmaceuticals and Eli Lilly. He was …
-
Hormone Therapy and Dementia: What Do We Know?
31 Oct 2024 15:16 GMT
… , to which Eli Lilly and Avid Radiopharmaceuticals, donated supplies. She is funded …
-
Risk of ARIA-E in Donanemab Attenuated Through New Enhanced Titration Method of Delivery
30 Oct 2024 14:02 GMT
… Development Chief Medical Officer at Avid Radiopharmaceuticals, a subsidiary of Eli Lilly …